pMKO.1 GFP B55 alpha shRNA 3-1 Citations (2)

Originally described in: Identification of specific PP2A complexes involved in human cell transformation.
Chen W, Possemato R, Campbell KT, Plattner CA, Pallas DC, Hahn WC Cancer Cell. 2004 Feb . 5(2):127-36. PubMed Journal

---

Articles Citing pMKO.1 GFP B55 alpha shRNA 3-1

Articles
A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program. Lin S, Ptasinska A, Chen X, Shrestha M, Assi SA, Chin PS, Imperato MR, Aronow BJ, Zhang J, Weirauch MT, Bonifer C, Mulloy JC. Blood. 2017 Sep 7;130(10):1213-1222. doi: 10.1182/blood-2016-11-750976. Epub 2017 Jul 14. PubMed
Functional importance of PP2A regulatory subunit loss in breast cancer. Watt LF, Panicker N, Mannan A, Copeland B, Kahl RGS, Dun MD, Young B, Roselli S, Verrills NM. Breast Cancer Res Treat. 2017 Nov;166(1):117-131. doi: 10.1007/s10549-017-4403-5. Epub 2017 Jul 25. PubMed

If you have published an article using this material, please email us at to have your article added to this page.